Chlorsol 50% Powder For Oral Solution
Revised: January 2013
AN: 01190/2012
SUMMARY OF PRODUCT CHARACTERISTICS
1. Name of the veterinary medicinal product
Chlorsol 50% Powder for Oral Solution
2. Qualitative and quantitative composition:
Active substance:
Chlortetracycline Hydrochloride 50% w/w
For a full list of excipients, see section 6.1
3. Pharmaceutical form
Powder for oral solution.
4. Clinical particulars
4.1 Target species
Broiler chickens and pigs.
4.2 Indications for use
For use in the treatment of infections due to susceptible bacteria in broiler chickens and pigs.
Chickens: Chlorsol 50 is used in the treatment and control of colibacillosis secondary to infectious bursal disease, chronic respiratory disease caused by Mycoplasma gallisepticumand Escherichia coli, and Salmonella enteridis, Salmonella typhimuriumand Pasteurella multocidainfections.
Pigs: Chlorsol 50 is used in the treatment and control of respiratory diseases associated with Mycoplasma hyopneumoniae, Steptococcus suisand toxigenic strains of Pasteurella multocida. It is also used in the treatment and control of rhinitis due to Bordetella bronchisepticaand streptococcal meningitis due to Streptococcus suistype II.
4.3 Contra-indications
None Known
4.4 Special warnings for each target species
None Known
4.5 Special precautions for use
i. Special precautions for use in animals
Once opened, the entire contents of the 200g sachet must be added to the required quantity of water. After opening the inner sachet of a 2kg pack, seal after use and keep container tightly closed. Once inner sachet has been opened, contents must be used within 7 days. Any medicated water, which is not consumed within 24 hours, should be discarded safely.
Chickens and pigs should have access only to medicated water during treatment
ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals
Avoid inhalation of dust by wearing a protective mask. Wear either disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143.
In case of accidental spillage on to the skin or eyes, wash the affected area with clean running water immediately. Seek medical attention if irritation occurs/persists. Wash hands thoroughly after using this product.
4.6 Adverse reactions (frequency and seriousness)
Not applicable
4.7 Use during pregnancy, lactation or lay
Do not administer Chlorsol 50 to pregnant sows, see also 4.3
4.8 Interaction with other medicaments and other forms of interaction
Absorption of chlortetracycline from the alimentary tract is reduced by calcium, iron, magnesium and zinc salts.
4.9 Amounts to be administered and administration route
Chlorsol 50 is recommended for oral administration in drinking water. For the 2kg pack a level scoop contains approximately 20g of powder.
Chickens: 200g of product should be dissolved in 600L of drinking water and administered daily for up to 5 days. This will provide a daily dosage of 20 - 50mg Chlortetracycline HCl/kg depending on water consumption. Dosage may be adjusted to up to 60mg/kg depending upon the severity of infection, by careful calculation of the total bodyweight of the birds and dissolving the requisite amount of Chlorsol 50 in the quantity of water consumed within 24 hours.
Pigs: In order to achieve the recommended dosage rate of 20mg Chlortetracycline HCl/kg, 200g of product should be dissolved in 500L of water and administered daily for up to 5 days. This will provide medication for 5000kg of pigs. Allowance for wastage of medicated water and reduced water intake should be made and the necessary adjustment made to the amount of product used.
Medicated water should be prepared daily and any unused water should be discarded safely. Chickens and pigs should have access only to medicated water during treatment.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
No specific antidote is available.
4.11 Withdrawal period(s)
Chickens 3 days
Pigs 6 days
Not for use in laying birds producing eggs for human consumption.
Pharmacological properties
ATC Vet Code:QJ01AA03 Antibacterials for systemic use (chlortetracycline)
5.1 Pharmacodynamic properties
Chlortetracycline hydrochloride is a bacteriostatic antibiotic belonging to the tetracycline group, which acts by inhibition of protein synthesis.
5.2 Pharmacokinetic properties
Chlortetracycline hydrochloride is readily absorbed and distributed in the tissues in chickens and pigs. Blood concentrations may be enhanced by administration with citric acid.
6. Pharmaceutical particulars
6.1 List of excipients
Anhydrous citric acid
6.2 Incompatibilities
Absorption of chlortetracycline from the alimentary tract is reduced by calcium, iron, magnesium and zinc salts.
6.3 Shelf-life
Powder: The shelf-life of the unopened sachet is 24 months. Once opened the entire contents of a 200g sachet must be used at once. Once inner sachet of 2kg pack has been opened, contents must be used within 7 days.
On dilution: Any medicated water that is not consumed within 24 hours should be discarded safely.
6.4 Special precautions for storage
Store in a dry place.
Do not store above 25°C.
6.5 Nature and composition of immediate packaging
The product is available in two pack sizes: A laminated foil sachet containing 200g of the product or a laminated foil sachet containing 2kg of the product supplied in a polypropylene bucket with a polypropylene or polyethylene snap fit lid and 25 ml scoop. The product is a free flowing yellow powder.
6.6 Special precautions for the disposal of unused veterinary medicinal product of waste materials derived from the use of such products if appropriate
Any unused product or waste material should be disposed of in accordance with national requirements.
7. MARKETING AUTHORISATION HOLDER
Vétoquinol UK Limited
Vétoquinol House
Great Slade
Buckingham Industrial Park
Buckingham
MK18 1PA
8. MARKETING AUTHORISATION NUMBERS
IE: VPA 10966/11/1
UK: Vm08007/4052
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Date: 7August 1995/7 August 2005
DATE OF REVISION OF THE TEXT
Date: December 2012
Approved:
03/01/13
Page 5 of 5